The use of periinfarct contrast-enhanced cardiac magnetic resonance imaging for the prediction of late postmyocardial infarction ventricular dysfunction

American Heart Journal

Volumn 156, Issue 3, 2008, Pages 498-505

  Rubenstein, Jason C ^a   Ortiz, José T ^a   Wu, Edwin ^a   Kadish, Alan ^a   Passman, Rod ^a   Bonow, Robert O ^a   Goldberger, Jeffrey J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; DEFIBRILLATOR; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STUNNED HEART MUSCLE; SUDDEN DEATH;

AGED; CONTRAST MEDIA; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION;

EID: 49949108328     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.04.012     Document Type: Article

References (34)

1. Solomon S.D., Zelenkofske S., McMurray J.J.V., et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
2. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
4. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
5. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
6. Sonnenblick E.H., and Sonnenblick E.H. Correlation of myocardial ultrastructure and function. Circulation 38 (1968) 29-44
7. Bassand J.P., and Bassand J.P. Left ventricular remodelling after acute myocardial infarction-solved and unsolved issues. Eur Heart J 16 Suppl I (1995) 58-63
8. Chaitman B.R., DeMots H., Bristow J.D., et al. Objective and subjective analysis of left ventricular angiograms. Circulation 52 (1975) 420-425
9. de Chillou C., Lacroix D., Klug D., et al. Isthmus characteristics of reentrant ventricular tachycardia after myocardial infarction. Circulation 105 (2002) 726-731
10. Josephson M.E., Horowitz L.N., Farshidi A., et al. Recurrent sustained ventricular tachycardia. 1. Mechanisms. Circulation 57 (1978) 431-440
11. Wilber D.J., Lynch J.J., Montgomery D., et al. Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model. Am Heart J 109 (1985) 8-18
12. Wu E, Ortiz JT, Tejedor P. et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart [In press].
13. Wu E., Ortiz J.T., Kansal P., et al. Infarct mass by contrast-enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index. Circulation 114 (2006) II_461 (abstr 2258)
14. Simonetti O., Kim R., and Fieno D. An improved MR imaging technique for the visualization of myocardial infarction. Radiology (2001) 215-223
15. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
16. Wu E., Judd R.M., Vargas J.D., et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357 (2001) 21-28
17. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
18. Cheema A.N., Sheu K., Parker M., et al. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: tachycardia characteristics and their prognostic implications. Circulation 98 (1998) 2030-2036
19. Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 309 (1983) 331-336
20. Zaret B.L., Wackers F.J.T., Terrin M.L., et al. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) Phase II Study. J Am Coll Cardiol 26 (1995) 73-79
21. Grothues F., Smith G.C., Moon J.C.C., et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90 (2002) 29-34
22. Bulow H., Klein C., Kuehn I., et al. Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease. Heart 91 (2005) 1158-1163
23. Pfeffer M.A., McMurray J.J.V., Velazquez E.J., et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 (2003) 1893-1906
24. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
25. Raviele A., Bongiorni M.G., Brignole M., et al. Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial. Europace 7 (2005) 327-337
26. Ross A.M., Coyne K.S., Moreyra E., et al. Extended mortality benefit of early postinfarction reperfusion. Circulation 97 (1998) 1549-1556
27. Uusimaa P., Risteli J., Niemela M., et al. Collagen scar formation after acute myocardial infarction : relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 96 (1997) 2565-2572
28. Beek A.M., Kuhl H.P., Bondarenko O., et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 42 (2003) 895-901
29. Choi K.M., Kim R.J., Gubernikoff G., et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104 (2001) 1101-1107
30. Gerber B.L., Garot J., Bluemke D.A., et al. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 106 (2002) 1083-1089
31. Bello D., Fieno D.S., Kim R.J., et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45 (2005) 1104-1108
32. Klocke F.J., Wu E., and Lee D.C. "Shades of gray" in cardiac magnetic resonance images of infarcted myocardium: can they tell us what we'd like them to. Circulation 114 (2006) 8-10
33. Yan A.T., Shayne A.J., Brown K.A., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114 (2006) 32-39
34. Schmidt A., Azevedo C.F., Cheng A., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115 (2007) 2006-2014